Who are Hologic's decision-makers?
Hologic is led by Stephen P. MacMillan. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, compliance, finance, and operational stakeholders.
- CEO
- Stephen P. MacMillan
- CFO/key exec
- Karleen Oberton
- Founded
- 1985
- Employees
- 7,000+
- HQ
- Marlborough, MA
- Status
- Nasdaq: HOLX
- Stephen P. MacMillanChairman, President and Chief Executive OfficerCEO since 2013Leads Hologic's women's-health strategy and M&A program.
- Karleen ObertonChief Financial OfficerCFO since 2018Finance leader for diagnostics, imaging, and capital allocation.
- Esmeralda NegronPresident, Diagnostics SolutionsSenior executive leadershipLeads molecular diagnostics and Panther platform priorities.
- Erik AndersonPresident, Breast and Skeletal Health SolutionsSenior executive leadershipLeads breast imaging and skeletal health businesses.
Who leads Hologic?
Hologic's leadership team combines enterprise healthcare operations, finance, clinical, product, technology, legal, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at Hologic?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, data-security, compliance, privacy, and implementation owners. Clinical, reimbursement, or quality stakeholders become essential whenever the purchase touches patient care, regulated data, medical products, or payer/provider economics.
How is Hologic organized as it scales?
Hologic operates through business units tied to Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. That creates multiple entry points, but enterprise standards for security, compliance, contracting, and vendor management can still control the final approval path.
As of June 2026.Sources:Hologic leadershipHologic annual reports
Hologic — frequently asked questions
